Gunther Neeck

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14

Adrenal secretion of cortisol in patients with rheumatoid arthritis.

Gunther Neeck, K. Federlin, Graef et al. · PubMed · 1990 · 239 citations

Immunology, Glucocorticoid, Inflammatory Arthritis +18

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 208 citations

Rheumatology, Spondyloarthritis, Rheumatic Diseases +8

Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients

Gunther Neeck · Scandinavian Journal of Rheumatology · 2000 · 73 citations

Pain Medicine, Fibromyalgia, Pain Syndrome +20

Serum amyloid A - an indicator of inflammation in ankylosing spondylitis

Uwe Lange, B. Boss, J. Teichmann et al. · Rheumatology International · 2000 · 71 citations

Inflammation, Rheumatology, Autoimmune Disease +8